Cauloside A

Cauloside A at a Glance

Cauloside A is an oleanane-type triterpene saponin — a molecule of hederagenin carrying a single arabinose sugar at the 3-position (hederagenin 3-O-α-L-arabinopyranoside). It is one of the caulosides, the saponin family named for and characteristic of blue cohosh (Caulophyllum thalictroides) and its Asian relative C. robustum ^{1Reference 1Strigina LI et al. · 1975Cauloside D, a new triterpenoid glycoside from Caulophyllum robustum Maxim: identification of cauloside AView study →}.

Almost everything cauloside A does traces to one property: as an amphiphilic monodesmosidic saponin it disrupts sterol-containing membranes. That single mechanism cuts two ways. In cancer-cell work it drives a genuine cytotoxic / antitumour signal — a 2026 study reported that cauloside A engages TLR4 to trigger GSDME-dependent pyroptosis in non-small-cell lung-cancer cells and slowed tumour growth in mice ^{3Reference 3Wang QQ et al. · 2026Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cellsView study →}. In the toxicological setting the same membrane-wrecking behaviour makes it mitochondriotoxic and a contributor to the caulosides’ cytotoxicity and gastrointestinal irritancy ^{2Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →}.

It has no established human medical use. It is a large, poorly-absorbed glycoside; the antitumour data are preclinical, and the compound in that study was isolated from Akebia fruit rather than blue cohosh ^{3Reference 3Wang QQ et al. · 2026Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cellsView study →}. This page treats cauloside A as what it is — a membrane-active plant saponin — not as a therapy.

A Hederagenin Saponin: Membrane & Mitochondrial Disruption

The point of the molecule is its surfactant-like, membrane-destabilising action, and it is worth understanding once because it explains both the “good” (antitumour cytotoxicity) and the “bad” (irritancy, mitochondrial poisoning).

Cauloside A is monodesmosidic — it has one sugar chain, attached only at C-3, leaving hederagenin’s free carboxylic acid at C-28. This matters. Among hederagenin saponins, it is the monodesmosides with a free C-28 acid (not the bisdesmosides that also glycosylate C-28) that are the strongly membrane-active, haemolytic and cytotoxic ones; the sugar chain and the state of the aglycone’s carboxyl together set the potency ^{7Reference 7Chwalek M et al. · 2006Structure-activity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis inductionView study →}. Cauloside A sits on the active side of that line, whereas its C-28-glycosylated sibling cauloside D is the corresponding bisdesmoside.

Mechanistically these saponins behave as amphiphiles that insert into cholesterol-containing membranes, destabilising the bilayer, permeabilising it and lysing cells (the classic saponin haemolysis) ^{7Reference 7Chwalek M et al. · 2006Structure-activity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis inductionView study →}. Applied to mitochondria, that same insertion breaches the inner membrane: in a screen of 352 botanicals, blue-cohosh extract and its purified saponins — cauloside A, saponin PE and cauloside C — caused a fast, concentration- and time-dependent spike in cell respiration followed by collapse, and were shown to impair mitochondrial function by disrupting membrane integrity rather than by inhibiting a specific respiratory complex ^{2Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →}. The authors framed this as a plausible link between the caulosides and blue cohosh’s rare but severe idiosyncratic organ toxicity ^{2Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →}.

What It's Used For

The research base is small and splits cleanly: one recent antitumour mechanism paper, a toxicological membrane/mitochondrial line, and a traditional herbal attribution that was never pinned to this isolate.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Every row here is preclinical (cell/animal or inference); no human data exist, so scores stay low by design.

01Antitumour / cytotoxic (pyroptosis)Shaky36%One 2026 isolate study, cell + mouse; TLR4/GSDME; compound from Akebia ^{3,2Reference 3Wang QQ et al. · 2026Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cellsView study →Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →}

02Mitochondrial & membrane cytotoxicityShaky30%In-vitro on the purified blue-cohosh saponin; saponin membrane SAR ^{2,7Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →Reference 7Chwalek M et al. · 2006Structure-activity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis inductionView study →}

03Uterine stimulant (herbal, saponin fraction)Shaky16%Traditional attribution to the whole saponin fraction, not the isolate ^{6Reference 6Ganzera M et al. · 2003Determination of saponins and alkaloids in Caulophyllum thalictroides (blue cohosh) by high-performance liquid chromatography and evaporative light scattering detectionView study →}

Mechanisms

The through-line is the first two rows: one membrane-disrupting property that reads as “cytotoxic antitumour agent” in a cancer cell and “mitochondrial toxin / irritant” in a healthy one. The TLR4/GSDME axis is a specific, receptor-level mechanism layered on top, reported in a single study ^{3Reference 3Wang QQ et al. · 2026Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cellsView study →}.

Pharmacokinetics

Cauloside A is a large, polar triterpene monoglycoside, the physicochemical profile that makes saponins poorly absorbed after oral dosing — a first-order caveat on any oral relevance of the in-vitro potency. Where it has been tracked in vivo, it appears as a circulating metabolite of the larger saponin asperosaponin VI: after oral asperosaponin VI, cauloside A was quantified in plasma by LC-MS/MS with a Tmax of about 9.3 h ^{4Reference 4Liu EW et al. · 2014Pharmacokinetics study of asperosaponin VI and its metabolites cauloside A, HN saponin F and hederageninView study →}, consistent with slow appearance via gut/hepatic deglycosylation of a parent saponin rather than direct rapid uptake. Its own further deglycosylation product is the aglycone hederagenin ^{4Reference 4Liu EW et al. · 2014Pharmacokinetics study of asperosaponin VI and its metabolites cauloside A, HN saponin F and hederageninView study →}. No absolute oral bioavailability, Cmax or half-life is established for cauloside A itself, and no human PK data exist.

Clinical Trials

There are no clinical trials of cauloside A — as an isolate or as a defined product. The entire evidence base is preclinical: cell and mouse pharmacology ^{3Reference 3Wang QQ et al. · 2026Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cellsView study →}, in-vitro mitochondrial toxicology ^{2Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →}, and analytical/PK characterisation ^{4Reference 4Liu EW et al. · 2014Pharmacokinetics study of asperosaponin VI and its metabolites cauloside A, HN saponin F and hederageninView study →}.

Last checked: July 2026.

Isolate vs. Plant Studies

The evidence here is unusually isolate-heavy, but with a twist. The mitochondrial-toxicity work tested the purified blue-cohosh saponin (cauloside A, saponin PE, cauloside C) directly against the parent extract, so that link between molecule and herb is well made ^{2Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →}. The antitumour study also used the isolated molecule — a strength for attribution — but the isolate was sourced from Akebia fruit (Fructus Akebiae), not blue cohosh ^{3Reference 3Wang QQ et al. · 2026Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cellsView study →}, so it speaks to the molecule rather than to blue cohosh specifically. The one genuinely plant/fraction-level claim, the uterine-stimulant reputation, was never resolved to this compound and is best read as a property of the whole saponin fraction ^{6Reference 6Ganzera M et al. · 2003Determination of saponins and alkaloids in Caulophyllum thalictroides (blue cohosh) by high-performance liquid chromatography and evaporative light scattering detectionView study →}. Net: good molecule-level attribution for the toxicology, a single-study molecule-level antitumour signal from a different plant source, and no isolate-grade evidence for the traditional use.

Prevalence in Nature

Cauloside A is a saponin of the genus Caulophyllum: it was characterised from C. robustum ^{1Reference 1Strigina LI et al. · 1975Cauloside D, a new triterpenoid glycoside from Caulophyllum robustum Maxim: identification of cauloside AView study →} and is present, with the other caulosides (B, C, D, G, H, leonticin D, saponin PE), in the roots and rhizome of blue cohosh (Caulophyllum thalictroides) ^{2,5Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →Reference 5Avula B et al. · 2011Analytical methods for determination of magnoflorine and saponins from roots of Caulophyllum thalictroides (L.) Michx. using UPLC, HPLC and HPTLCView study →}. Beyond the genus it is reported from Akebia (Fructus Akebiae) ^{3Reference 3Wang QQ et al. · 2026Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cellsView study →} and appears as a metabolite of asperosaponin VI, a saponin of teasel root (Dipsacus asper) ^{4Reference 4Liu EW et al. · 2014Pharmacokinetics study of asperosaponin VI and its metabolites cauloside A, HN saponin F and hederageninView study →} — unsurprising, since all share the hederagenin aglycone.

It is not reliably quantified as a single compound. Analytical methods can separate cauloside A from the other seven blue-cohosh saponins ^{5Reference 5Avula B et al. · 2011Analytical methods for determination of magnoflorine and saponins from roots of Caulophyllum thalictroides (L.) Michx. using UPLC, HPLC and HPTLCView study →}, but published figures are for total saponins, which vary enormously between products — more than 100-fold across commercial blue-cohosh preparations, with total-saponin intakes estimated from roughly 6 to 300 mg/day depending on the product form and label dose ^{5,6Reference 5Avula B et al. · 2011Analytical methods for determination of magnoflorine and saponins from roots of Caulophyllum thalictroides (L.) Michx. using UPLC, HPLC and HPTLCView study →Reference 6Ganzera M et al. · 2003Determination of saponins and alkaloids in Caulophyllum thalictroides (blue cohosh) by high-performance liquid chromatography and evaporative light scattering detectionView study →}. Per-compound concentrations for cauloside A specifically are a documented gap.

Discovery & Synthesis

Cauloside A belongs to a set of saponins worked out by Soviet natural-product chemists at the Pacific Institute of Bioorganic Chemistry in Vladivostok — the group of L. I. Strigina and G. B. Elyakov — from Caulophyllum robustum. Its structure, hederagenin 3-O-α-L-arabinopyranoside, was confirmed in the course of characterising the related cauloside D, where cauloside A was shown to be identical to a saponin (“saponin A”) isolated earlier ^{1Reference 1Strigina LI et al. · 1975Cauloside D, a new triterpenoid glycoside from Caulophyllum robustum Maxim: identification of cauloside AView study →}. The family name cauloside derives directly from the genus Caulophyllum; cauloside A also appears in the literature under the synonyms Koelreuterii-saponin A and Tauroside B.

There is no commercial manufacture of cauloside A. It is obtained by extraction and chromatographic isolation from Caulophyllum (or Akebia) plant material for research use; there is no established total synthesis, which for a glycosylated triterpene of this size would be a substantial undertaking and is not the route anyone uses to obtain it.

Patents: not yet researched.

Toxicity & Safety

Cauloside A carries a moderate flag. As a purified saponin it is cytotoxic, haemolytic and directly mitochondriotoxic in vitro ^{2,7Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →Reference 7Chwalek M et al. · 2006Structure-activity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis inductionView study →} — properties that place it above an inert phytochemical. Two things keep it at moderate rather than higher: it is a large, poorly-absorbed glycoside, so systemic exposure from oral herbal use is limited; and blue cohosh’s genuinely severe documented harms (teratogenicity, perinatal cardiovascular events) are attributed chiefly to its quinolizidine alkaloids (N-methylcytisine, anagyrine), not to the caulosides ^{6Reference 6Ganzera M et al. · 2003Determination of saponins and alkaloids in Caulophyllum thalictroides (blue cohosh) by high-performance liquid chromatography and evaporative light scattering detectionView study →}. The saponins’ plausible contribution is to the herb’s cytotoxicity and gastrointestinal irritancy, and as a possible factor in its rare idiosyncratic organ toxicity ^{2Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →}.

Safety at a Glance

⚠️ Moderate toxicity

• Poorly absorbed after oral intake. As a large, polar triterpene saponin, systemic exposure from ordinary herbal use is limited — the in-vitro potency does not translate directly to an oral dose.
• Membrane-disrupting and mitochondriotoxic in vitro. The purified saponin destabilises cell and mitochondrial membranes (haemolysis, respiration collapse); it is one of the blue-cohosh constituents flagged for mitochondrial toxicity ^{2,7Reference 2Datta S et al. · 2014Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potentialView study →Reference 7Chwalek M et al. · 2006Structure-activity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis inductionView study →}.
• Saponin-class GI irritancy. Membrane-active saponins irritate the gut lining and contribute to the nausea/cramping associated with the herb’s saponin fraction.
• The herb’s severe risks are largely the alkaloids, not this molecule. Blue cohosh’s teratogenic and perinatal harms track its quinolizidine alkaloids; do not read cauloside A’s cytotoxicity as the source of those specific outcomes ^{6Reference 6Ganzera M et al. · 2003Determination of saponins and alkaloids in Caulophyllum thalictroides (blue cohosh) by high-performance liquid chromatography and evaporative light scattering detectionView study →}. Reproductive/pregnancy decisions belong to the herb page, where intake is decided.

Dosage

There is no established or recommended human dose for cauloside A. It is not a supplement and has no clinical use; the antitumour findings are preclinical (cell and mouse), and the effective concentrations in those studies are laboratory exposures, not oral doses ^{3Reference 3Wang QQ et al. · 2026Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cellsView study →}.

The only human-relevant figures are indirect and fraction-level: total triterpene saponins in commercial blue-cohosh products span roughly 6–300 mg/day with more than 100-fold variation between products, of which cauloside A is one minor constituent ^{5,6Reference 5Avula B et al. · 2011Analytical methods for determination of magnoflorine and saponins from roots of Caulophyllum thalictroides (L.) Michx. using UPLC, HPLC and HPTLCView study →Reference 6Ganzera M et al. · 2003Determination of saponins and alkaloids in Caulophyllum thalictroides (blue cohosh) by high-performance liquid chromatography and evaporative light scattering detectionView study →}. These are analytical characterisations of herbal products, not a personal recommendation.

References

1. Strigina LI, Chetyrina NS, Isakov VV, Elkin YuN, Dzizenko AK, Elyakov GB (1975). Cauloside D, a new triterpenoid glycoside from Caulophyllum robustum Maxim: identification of cauloside A. Phytochemistry. https://doi.org/10.1016/0031-9422(75)85355-6
2. Datta S, Mahdi F, Ali Z, Jekabsons MB, Khan IA, Nagle DG, Zhou YD (2014). Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potential. Journal of Natural Products. https://pubmed.ncbi.nlm.nih.gov/24328138/
3. Wang QQ, Zhao W, Liu L, Ni X, Shen Y, Xiao L, Yao X, Feng Y, Yang S, Yuan R, Gao H (2026). Cauloside A interacts with TLR4 to induce JNK/Caspase-3/GSDME-dependent pyroptosis in non-small cell lung cancer cells. International Immunopharmacology. https://pubmed.ncbi.nlm.nih.gov/42085840/
4. Liu EW, Wang JL, Han LF, Chang YX, Wang T, Huo Y, Wang L, Gao XM (2014). Pharmacokinetics study of asperosaponin VI and its metabolites cauloside A, HN saponin F and hederagenin. Journal of Natural Medicines. https://pubmed.ncbi.nlm.nih.gov/24615060/
5. Avula B, Wang YH, Rumalla CS, Ali Z, Smillie TJ, Khan IA (2011). Analytical methods for determination of magnoflorine and saponins from roots of Caulophyllum thalictroides (L.) Michx. using UPLC, HPLC and HPTLC. Journal of Pharmaceutical and Biomedical Analysis. https://pubmed.ncbi.nlm.nih.gov/21872415/
6. Ganzera M, Dharmaratne HR, Nanayakkara NP, Khan IA (2003). Determination of saponins and alkaloids in Caulophyllum thalictroides (blue cohosh) by high-performance liquid chromatography and evaporative light scattering detection. Phytochemical Analysis. https://pubmed.ncbi.nlm.nih.gov/12597249/
7. Chwalek M, Lalun N, Bobichon H, Plé K, Voutquenne-Nazabadioko L (2006). Structure-activity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis induction. Biochimica et Biophysica Acta. https://pubmed.ncbi.nlm.nih.gov/16875785/

View all 7 references▾